report cover1

Conjugate Vaccine Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

A conjugate vaccine is a type of subunit vaccine that combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen. Vaccines are used to prevent diseases by invoking an immune response to an antigen, part of a bacterium or virus that the immune system recognizes. This is usually accomplished with an attenuated or dead version of a pathogenic bacterium or virus in the vaccine so that the immune system can recognize the antigen later in life. Most vaccines contain a single antigen that the body will recognize. However, the antigen of some pathogens does not elicit a strong response from the immune system, so a vaccination against this weak antigen would not protect the person later in life. A conjugate vaccine is used to invoke an immune system response against the weak antigen. In a conjugate vaccine, the weak antigen is covalently attached to a strong antigen, thereby eliciting a stronger immunological response to the weak antigen. The weak antigen is a polysaccharide that is attached to a strong protein antigen. However, peptide/protein and protein/ protein conjugates have also been developed.

The most commonly used conjugate vaccine is the Hib conjugate vaccine. Other pathogens that are combined in a conjugate vaccine to increase an immune response are Streptococcus pneumoniae. Vaccines evoke an immune response to an antigen, and the immune system reacts by producing T cells and antibodies. The B memory cells remember the antigen so that if the body encounters it later, antibodies can be produced by B cells to break down antigens for bacteria with a polysaccharide coating, the immune response creates B cells independent of T cell stimulation. A T cell response can be induced by conjugating the polysaccharide to a protein carrier.

Global Conjugate Vaccine Market – Competitive Landscape

On August 9, 2023, SK Bioscience announced an equity investment in Novavax to strengthen strategic partnerships. On July 12, 2023, Biosynth acquired Celares for the growing conjugate vaccine market. On November 11, 2021, the Gates Foundation poured USD 90 million into the promised new pneumococcal vaccine.  On January 8, 2021, Affinivax announced USD 226 million Series C financing to advance its pipeline of Novel MAPS™ vaccines targeting infectious diseases.

Some of the Key Players in the Global Conjugate Vaccine Market Include –

  • Merck and Company
  • GlaxoSmithKline Plc
  • CSL Limited
  • Biological E, Bharat Biotech
  • Neuron Biotech
  • Novartis AG
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India

Global Conjugate Vaccine Market – Growth Drivers

Growing awareness about the importance of vaccination and the prevention of diseases is a key driver for the global conjugate vaccine market. Supportive government policies and initiatives to enhance vaccination coverage contribute to the market’s growth. Continuous advancements in vaccine development technologies, including conjugate vaccine research, drive market expansion. The increasing prevalence of infectious diseases, especially in developing regions, fuels the demand for effective vaccines, propelling market growth. According to BMC Infectious Disease, the overall prevalence of infectious disease syndrome was 71.8/10,000 population worldwide. International efforts and collaboration to improve immunization coverage globally positively impact the demand for conjugate vaccines. Integrating conjugate vaccines into routine pediatric immunization schedules worldwide contributes significantly to market growth. Conjugate vaccines demonstrated efficacy and safety profile enhancing their adoption and fostering market growth. Ongoing research and development, along with technological innovations in vaccine formulation and delivery, drive the market’s evolution. Growing investments in healthcare infrastructure and research contribute to the development and availability of conjugate vaccines. The rise in international travel increases the risk of disease transmission, boosting the demand for vaccines, including conjugate vaccines, for preventive measures.

Global Conjugate Vaccine Market – Restraints

The complex production processes involved in manufacturing conjugate vaccines contribute to elevated production costs, significantly restraining market growth. Accessibility challenges, particularly in developing regions, hinder the widespread adoption of conjugate vaccines, impacting market penetration. According to Lancet the expected cost of pneumococcal conjugate vaccination globally is around USD 16 billion per year. Stringent regulatory requirements and lengthy approval processes can delay the market entry of new conjugate vaccines, posing a restraint on timely product launches. The necessity for a cold chain infrastructure to maintain vaccine efficacy poses a logistical challenge, particularly in regions with inadequate cold storage facilities. Increasing vaccine hesitancy and skepticism in certain populations can impede the acceptance and uptake of conjugate vaccines affecting market growth. In certain communities there may be a lack of awareness regarding the benefits of conjugate vaccines, limiting their acceptance and utilization. Intense competition within the vaccine market can lead to pricing pressures, affecting profit margins and potentially hindering investment in research and development. Inadequate numbers of skilled healthcare professionals especially in some developing regions, can limit the effective administration and promotion of conjugate vaccines. Concerns and fears related to perceived side effects of vaccines may contribute to hesitancy, impacting the acceptance and demand for conjugate vaccines in certain populations.

Global Conjugate Vaccine Market – Opportunities

Opportunities arise from the continuous expansion of national and international vaccination programs, creating a larger market for conjugate vaccines. Penetration into untapped and emerging markets presents a significant opportunity for the global conjugate vaccine market, especially in regions with increasing healthcare awareness. Ongoing advancements in vaccine technologies open avenues for the development of more effective and targeted conjugate vaccines, enhancing market potential. Strategic collaboration and partnership between pharmaceutical companies, research institutions, and government bodies can lead to increased research funding and accelerated vaccine development. Growing emphasis on preventive healthcare practices globally creates a favorable environment for the adoption of conjugate vaccines, presenting a substantial market opportunity. Increased awareness and emphasis on pandemic preparedness create opportunities for the development and stockpiling of conjugate vaccines to address potential outbreaks

Global Conjugate Vaccine Market – Geographical Insight

The market for global conjugate vaccines is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market due to vaccine research and development, fostering innovation in conjugate vaccine technologies. Europe witnessed increasing adoption of conjugate vaccines, supported by proactive immunization policies and a focus on preventive healthcare. The Asia-Pacific region experiences rapid market growth due to rising awareness, increasing healthcare investments, and expanding vaccination programs.

Global Conjugate Vaccine Market – Key Developments

  • On December 11, 2023, SK Bioscience, Sanofi started a phase III study of flu vaccine candidates with the US FDA.
  • On July 12, 2023, New typhoid conjugate vaccine Bio-TCV® was approved in Indonesia.
  • On June 30, 2023, SK bioscience-Sanofi announced positive results from the phase II study of a 21-valent pneumococcal conjugate vaccine candidate.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert